Answer
Jun 05, 2025 - 01:53 PM
Namenda, a medication used to treat moderate to severe Alzheimer's disease, was not discontinued entirely but rather its immediate-release version was phased out in favor of the extended-release version, Namenda XR. This decision was made to streamline production and encourage the use of the once-daily dosing option, which can improve patient adherence to the treatment regimen.
